Κυριακή 7 Μαρτίου 2021

Longitudinal assessment of anti-SARS-CoV-2 immune responses for six months based on the clinical severity of COVID-19

alkiviadis.1961 shared this article with you from Inoreader

pdf.svg

Abstract
There is insufficient data on the longevity of immunity acquired following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We aimed to evaluate the duration of SARS-CoV-2-specific humoral and cellular immunity according to the clinical severity of coronavirus disease 2019 (COVID-19). The study population comprised asymptomatic (n=14), symptomatic/non-pneumonic (n=42), and pneumonic (n=41) patients. The anti-SARS-CoV-2 IgG and neutralizing antibody (NAb) titers lasted until six mont hs after diagnosis, with positivity rates of 66.7% and 86.9%, respectively. Older age, prolonged viral shedding and accompanying pneumonia were more frequently found in patients with sustained humoral immunity. SARS-CoV-2 specific T-cell response was strongly observed in pneumonic patients and prominent in individuals with sustained humoral immunity. In conclusion, most (> 85%) patients carries NAb until six months after diagnosis of SARS-CoV-2 infection, providing insights for establishing vaccination strategies against COVID-19.
View on the web

Sex differences in the evolution of neutralizing antibodies to SARS-CoV-2

alkiviadis.1961 shared this article with you from Inoreader

pdf.svg

Abstract
We measured Anti-Spike (S), Nucleoprotein (N) and neutralizing antibodies (NAbs) in sera from 308 RT-qPCR + healthcare workers with mild disease, collected at two time-points up to 6 months after symptom onset. At Month 1 (M1), anti-S and N antibody levels were higher in males > 50 years or with a body mass index (BMI) > 25. At M3-6, anti-S and anti-N antibodies were detected in 99% and 59% of individuals, respectively. Anti-S antibodies and NAbs declined faster in males than in females, independently of age and BMI, suggesting an association of sex with evolution of the humoral response.
View on the web

Shedding of culturable virus, seroconversion, and 6-month follow-up antibody responses in the first 14 confirmed cases of COVID-19 in the United States

alkiviadis.1961 shared this article with you from Inoreader

pdf.svg

Abstract
We aimed to characterize presence of culturable virus in clinical specimens during acute illness, and antibody kinetics up to six months post-onset, among 14 early US COVID-19 patients. We isolated viable SARS-CoV-2 from rRT-PCR-positive respiratory specimens collected during days 0-8 post-onset, but not after. All 13 patients with two or more serum specimens developed anti-spike antibodies; 12 developed detectable neutralizing antibodies. We did not isolate virus after detection of neutralizing antibodie s. Eight participants provided serum at six months post-onset; all retained detectable anti-spike IgG, and half had detectable neutralizing antibodies. Two participants reported not feeling fully recovered at six months.
View on the web

Failure of nonoperative management in patients with acute diverticulitis complicated by abscess: a systematic review

alkiviadis.1961 shared this article with you from Inoreader

Abstract

Background

The aim of this study was to assess failure rates following nonoperative management of acute diverticulitis complicated by abscess and trends thereof.

Method

Pubmed, MEDLINE, EMBASE, CINAHL, Cochrane Library, and Web of Science were systematically searched. Nonoperative management was defined as a combination of nil per os, IV fluids, IV antibiotics, CT scan–guided percutaneous drainage, and total parenteral nutrition. The primary endpoint was failure of nonoperative management defined as persistent or worsening abscess and/or sepsis, development of new complications, such as peritonitis, ileus, or colocutaneous fistula, and urgent surgery within 30–90 days of index admission. Data were stratified by three arbitrary time intervals: 1986–2000, 2000–2010, and after 2010. The primary outcome was calculated for those groups and compared.

Results

Thirty-eight of forty-four eligible studies published between 1986 and 2019 were included in the quantitative synthesis of data (n = 2598). The pooled rate of failed nonoperative management was 16.4% (12.6%, 20.2%) at 90 days. In studies published in 2000–2010 (n = 405), the pooled failure rate was 18.6% (10.5%, 26.7%). After 2000 (n = 2140), the pooled failure rate was 15.3% (10.7%, 20%). The difference was not statistically significant (p = 0.725). After controlling for heterogeneity in the definition of failure of nonoperative management, subgroup analysis yielded the pooled rate of failure of 21.8% (16.1%, 27.4%).

Conclusion

This meta-analysis found that failure rates following nonoperative management of acute diverticulitis complicated by abscess did not significantly decrease over the past three decades. The general quality of published data and the level and certainty of evidence produced were low.

View on the web

Bartonella Neuroretinitis

alkiviadis.1961 shared this article with you from Inoreader
New England Journal of Medicine, Ahead of Print.
View on the web

Nucleoside‐modified messenger RNA (modRNA) COVID‐19 vaccine platform

alkiviadis.1961 shared this article with you from Inoreader

SUMMARY:

On March 11, 2020, the World Health Organization declared Coronavirus Disease 19 (COVID‐19) a pandemic; from that date the vaccine race has begun, and many technology platforms to develop a specific and effective COVID‐19 vaccine have been launched in several clinical trials (protein subunit, RNA‐based, DNA‐based, replicating viral vector, non‐replicating viral vector, inactivated virus, live attenuated virus and virus‐like particle). Among the next‐generation strategies, nucleoside‐modified messenger RNA (modRNA) vaccines appear the most attractive, not only to counteract emerging pathogens, but also for the possible applications in regenerative medicine and cancer therapy. However, exactly as all innovative drugs, they deserve a careful pharmacovigilance in the short and long term.

This article is protected by copyright. All rights reserved.

View on the web

The role of teicoplanin in the treatment of SARS‐CoV‐2 infection: a retrospective study in critically ill COVID‐19 patients (Tei‐COVID Study)

alkiviadis.1961 shared this article with you from Inoreader

ABSTRACT

INTRODUCTION

Teicoplanin has a potential antiviral activity expressed against SARS‐CoV‐2 and was suggested as a complementary option to treat COVID‐19 patients. In this multicentric, retrospective, observational research the aim was to evaluate the impact of teicoplanin on the course of COVID‐19 in critically ill patients.

METHODS

55 patients with severe COVID‐19, hospitalized in the ICUs and treated with best available therapy were retrospectively analysed. Among them 34 patients were also treated with teicoplanin (Tei‐COVID group), while 21 without teicoplanin (control group).

RESULTS

Crude in‐hospital day‐30 mortality was lower in Tei‐COVID group (35,2%) than in control group (42,8%), however not reaching statistical significance (p = 0.654). No statistically significant differences in length of stay in the ICU were observed between Tei‐COVID group and control group (p = 0.248). On day 14 from the ICU hospitalization, viral clearance was achieved in 64.7% patients of Tei‐COVID group and 57.1% of control group, without statistical difference. Serum C reactive Protein level was significantly reduced in Tei‐COVID group compared to control group, but not other biochemical parameters. Finally, Gram‐positive were the causative pathogens for 25% of BSIs in Tei‐COVID group and for 70,6% in controls. No side effects related to teicoplanin use were observed.

CONCLUSION

Despite several limitations require further research, in this study the use of teicoplanin is not associated with a significant improvement in outcomes analysed. The antiviral activity of teicoplanin against SARS‐CoV‐2, previously documented, is probably more effective at early clinical stages.

This article is protected by copyright. All rights reserved.

View on the web

Is obesity a manifestation of systemic racism? A ten‐point strategy for study and intervention

alkiviadis.1961 shared this article with you from Inoreader

Abstract

In the recent past, there has been rising attention to systemic racism. The ensuing discussions have largely focused on COVID‐19 and policing. Despite long‐standing disparities in obesity across racial and ethnic groups and obesity's important role in COVID‐19 disparities, there has been minimal attention to whether obesity itself could be a manifestation of systemic racism. Nor has there been serious policy attention dedicated to alleviating obesity and its disproportionate burden on BIPOC (Black, Indigenous, and People of Color). We discuss whether obesity's disproportionate harms to BIPOC may be attributed to systemic racism, and we provide a ten‐point strategy for studying and solving the core public health issues at the intersection of obesity and systemic racism.

View on the web

Systematic literature review of neutralizing antibody immune responses to non-vaccine targeted high-risk HPV types induced by the bivalent and the quadrivalent vaccines

alkiviadis.1961 shared this article with you from Inoreader
Via Vaccine

fbworm.png

CONCLUSIONS: The cross-protection antibody/immune response among participants having received all three doses of bivalent or quadrivalent vaccine is not comparable to the specific response elicited by HPV vaccine types. Even in cases where a statistically significant cross-reactive immunological response is reported, long-term data on the duration of the response beyond two years are very limited. Further, the lack of a standard for assays limits comparability of results between studies.PMID:33658126 | DOI:10.1016/j.vaccine.2021.01.060 (Source: Vaccine)
View on the web

Voltammetry of 7-dehydrocholesterol as a new and useful tool for Smith-Lemli-Opitz syndrome diagnosis

alkiviadis.1961 shared this article with you from Inoreader

1-s2.0-S0039914021001818-fx1.jpg

Publication date: Available online 6 March 2021

Source: Talanta

Author(s): Jan Klouda, Lenka Benešová, Pavel Kočovský, Karolina Schwarzová-Pecková

View on the web

Non-specific effects of BCG vaccination on neutrophil and lymphocyte counts of healthy neonates from a developed country

alkiviadis.1961 shared this article with you from Inoreader

1-s2.0-S0264410X21X00096-cov150h.gif

Publication date: Available online 6 March 2021

Source: Vaccine

Author(s): Sarah L. Williamson, Eleanor Gadd, Thillagavathie Pillay, Gergely Toldi

View on the web

Hearing about the Big Bang for the First Time

alkiviadis.1961 shared this article with you from Inoreader

C3A4CAB9-5677-42E6-8C5D8400B5D1978B.jpg

A jaded old science writer rediscovers the thrill of science by teaching undergraduates

-- Read more on ScientificAmerican.com
Attachments:
View on the web

Αρχειοθήκη ιστολογίου